Chris’ Corner: Diagnos Inc (ADK.V) Chris Parry September 2, 2021 Chris Parry speaks with Andre Larente, president and CEO of DIAGNOS (ADK.V) to get an in-depth look at how their diabetic retinopathy screening services work and what it means for optometrists and patients. Tune in! Biotech, Chris' Corner, Featured Content, Health Science, Parry, Scribes, Series, Video Related Posts This Week in Tech: Valuable or Pointless Divide Edition Diagnos (ADK.V) analysis – Chris’ Corner Diagnos (ADK.V) places well in artificial intelligence competition and prepares for CARA rollout Diagnos (ADK.V) Keeps Its Eye on the Prize, Secures Another Multi-Year Contract Diagnos (ADK.V) Partners with Cielo Vista Eye Clinic To Invest or Not: Diagnos (ADK.V) More on ADK.V This Week in Tech: Valuable or Pointless Divide Edition Joseph Morton March 18, 2022 Diagnos (ADK.V) analysis – Chris’ Corner Chris Parry November 12, 2021 Diagnos (ADK.V) places well in artificial intelligence competition and prepares for CARA rollout Joseph Morton October 28, 2021 Diagnos (ADK.V) Keeps Its Eye on the Prize, Secures Another Multi-Year Contract Kieran Robertson September 16, 2021 Diagnos (ADK.V) Partners with Cielo Vista Eye Clinic Kieran Robertson September 14, 2021 To Invest or Not: Diagnos (ADK.V) Reza Golzadeh September 2, 2021 Load More Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Name * Email * Website Comment * Save my name, email, and website in this browser for the next time I comment.
Diagnos (ADK.V) places well in artificial intelligence competition and prepares for CARA rollout Joseph Morton October 28, 2021
Diagnos (ADK.V) Keeps Its Eye on the Prize, Secures Another Multi-Year Contract Kieran Robertson September 16, 2021